MS
Therapeutic Areas
Eckert and Ziegler Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lu-177 Supply Partnerships | Prostate Cancer, Neuroendocrine Tumors | Commercial & Clinical Support |
| Brachytherapy Product Development | Prostate, Breast, Gynecological Cancers | Ongoing R&D |
| Novel Isotope Production (e.g., Ac-225) | Various Oncology | Pre-clinical / Early Development |
| Radiopharmaceutical Precursor Kits | Diagnostic Imaging | Commercial |
Leadership Team at Eckert and Ziegler
DH
Dr. Harald Hasselmann
Chief Executive Officer (CEO), Chairman of the Executive Board
DG
Dr. Gunnar Mann
Chief Operating Officer (COO)
FY
Frank Yeager
Chief Executive Officer, Segment Isotope Products
DD
Dr. Dirk Becker
Vice President Research & Development, Segment Medical
DA
Dr. Andreas Eckert
Chairman of the Supervisory Board